Epstein Files Search

EFTA01113062Set 9

2009-12-0910p8,245w

fold amplification of the optical scattering amplitude with the PNBs (relative to that of NPs), selective mechanical and fast damage to specific cells with bigger PNBs, and optical guidance ... agents due to their unique properties, such as the plasmon resonances of noble metal NPs, and without chemical Combining diagnosis and therapy in one process is an loads. Plasmon resonances ... applications. accuracy. The major promise of theranostics is to bring So far plasmon resonant NPs have demonstrated excellent together key stages of a medical treatment, such as the biocompatibility

https://www.justice.gov/epstein/files/DataSet%209/EFTA01113062.pdf

EFTA01613600Set 10

9p1,280w

2017/12/12 SSypt "contentType: 'application/vnd.microsoft.card.popur, "cardType": 1, "iconUrr: "https://secure.skypeassets.com/contenticlam/skypedimagests4l/engcardsinps_notif_hero_tjpg", "campaignGuid": "card-nps-desktop-1", 'quietCard": true, "platformList": [3, 4, 5), language': "en", i'validUntiMmestamp ... /contentidam/skype/imagests4liengcardsinps_heroi.jpg", "desktopUrfl"https://secure.skypeassets.com/contenticlamiskype/images/s4Vengcardstnps_hero_desktop.png". 'mediaType': 'image' ), "buttons': "actionUri": "https://go.slcype.conVfeedback.nps?langren&tag=card-nps-desktop-1", 'title': 'Take A Quick Survey" ) ) ) • ) 08:44:25 am EFTA01613601 2018;01/28 Scype ... 02/06 SkyPe "contentType: sapplication/vnd.microsoft.card.popur, "cardType": 1, "iconUrr: "https://secure.skypeassets.com/contenticlam/skypedimagests4l/engcardsinps_notif_hero_tjpg", "campaignGuid": "card-nps-desktop-1", 'quietCard": true, "platformList": [3, 4, 5), language': "en", "validUntiMmestamp

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01613600.pdf

EFTA01030621Set 9

2019-03-114p744w

customer experience or they will be challenged as the world changes. Please keep the NPS and dealer data confidential. Find a couple of articles that are worth a read ... data from Ford about the leads and applications generated through our platform 4. Customer NPS responses from the Month of March. The thought here was to frame up how dealers ... opportunity not a full aggregate level representation of the business today. 4. Attached NPS Survey Results in MID March. The reason I added these NPS surveys is it just shows

https://www.justice.gov/epstein/files/DataSet%209/EFTA01030621.pdf

EFTA02395064Set 11

2014-01-244p865w

orgsmozilla:en-US:official&tbs=ppl_ids:--1064=5982743019328629- ,ppl_nps:Clare+O%27Connor,ppl_aut:1> www.forbes.com/=../ <http://www.forbes.com/.../> jeffrey-epstein-sex-offender-yes-bil....=8E Forbes ... org.mozilla:en-US:official&tbs=ppl_ids:--106435982=43019328629- ,ppl_nps:Clare+O%27Connor,ppl_aut:1> - in 138 Google+ circles <https://plus.google.com/1064359827430193286=9> Feb 28, 2011- The pervert ... org.mozilla:en-US:official&tbs=ppl_ids:--1066=0046192173033978- ,ppl_nps:Amber+Sutherland,ppl_aut:1> nypost.=om/.../billionaire- <http://nypost.com/.../billionaire-> jeffrey-epstein-im-a-...4>=8E New York

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02395064.pdf

EFTA00598607Set 9

2014-07-2313p8,093w

Corporation, Infinity Pharmaceuticals Inc. InterMune. Ironwood Pharmaceuticals, Inc. Lexicon Pharmaceuticals. Inc., Neurocrine Biosciences Inc, NPS Pharmaceuticals, Ophthotech Corp. Pharmacyclics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc., Relypsa ... Infinity Pharmaceuticals Inc. InterMune, Ironwood Pharmaceuticals. Inc., Lexicon Pharmaceuticals. Inc.. Neurocrine Biosciences Inc, NPS Pharmaceuticals. Ophthotech Corp. Pharmacyclics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc.. Relypsa ... Pharmaceuticals Inc, InterMune, Ironwood Pharmaceuticals, Inc.. Lexicon Pharmaceuticals. Inc.. Neurocrine Biosciences Inc. NPS Pharmaceuticals, Ophthotech Corp. Pharmacyclics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc., Relypsa. Inc., Synageva

https://www.justice.gov/epstein/files/DataSet%209/EFTA00598607.pdf

EFTA00598622Set 9

14p8,563w

Infinity Pharmaceuticals Inc. InterMune. Ironwood Pharmaceuticals, Inc., Lexicon Pharmaceuticals. Inc.. Neurocrine Biosciences Inc. NPS Pharmaceuticals, Ophthotech Corp. Pharmacydics Inc.. Portola Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc., Relypsa ... infinity Pharmaceuticals Inc. InterMune, Ironwood Pharmaceuticals. Inc., Lexicon Pharmaceuticals. Inc.. Neurocrine Biosciences Inc, NPS Pharmaceuticals. Ophthotech Corp. Pharmacydics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc.. Relypsa ... Pharmaceuticals Inc, InterMune, Ironwood Pharmaceuticals. Inc.. Lexicon Pharmaceuticals. Inc.. Neurocrine Biosciences Inc, NPS Pharmaceuticals, Ophthotech Corp. Pharmacyclics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc., Relypsa. Inc., Synageva

https://www.justice.gov/epstein/files/DataSet%209/EFTA00598622.pdf

EFTA00797045Set 9

15p8,058w

potential risks. Understanding the experiences and perceptions of mentally disordered offenders who have used NPS. A qualitative study exploring the relationship between NPS use, mental health, offending behaviour and personality ... Kingdom Sampling the experiences and perceptions of mentally disordered offenders who use/ have used NPS. Exploring if there is a relationship between users, mental health difficulties, offending behaviour and personality ... University of Chemistry and Technology of Prague, Prague, Czech Republic Introduction: New psychoactive substances (NPS) are a fast-growing family of illicit drugs' substituents. This phenomenon becomes as a grey

https://www.justice.gov/epstein/files/DataSet%209/EFTA00797045.pdf

EFTA01199422Set 9

14p8,572w

Infinity Pharmaceuticals Inc. InterMune. Ironwood Pharmaceuticals, Inc., Lexicon Pharmaceuticals. Inc.. Neurocrine Biosciences Inc. NPS Pharmaceuticals, Ophthotech Corp. Pharmacydics Inc.. Portola Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc., Relypsa ... infinity Pharmaceuticals Inc. InterMune, Ironwood Pharmaceuticals. Inc., Lexicon Pharmaceuticals, Inc.. Neurocrine Biosciences Inc, NPS Pharmaceuticals. Ophthotech Corp. Pharmacydics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc.. Relypsa ... Pharmaceuticals Inc, InterMune, Ironwood Pharmaceuticals. Inc.. Lexicon Pharmaceuticals. Inc.. Neurocrine Bioscienoes Inc, NPS Pharmaceuticals, Ophthotech Corp. Pharmacyclics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc., Relypsa. Inc., Synageva

https://www.justice.gov/epstein/files/DataSet%209/EFTA01199422.pdf

EFTA00263534Set 9

2022-05-1942p8,836w

Official Receipt Attention:Jacqueline Customer ABN. Customer 11-1 CMR Date:09 Aug 2012 NPS Receipt: NPS Batch: Non NPS Receipt: 77047195 Non NPS Batch: 7681771 PBR Receipt: Description Amount

https://www.justice.gov/epstein/files/DataSet%209/EFTA00263534.pdf

EFTA01199408Set 9

2014-07-2313p8,089w

Corporation, Infinity Pharmaceuticals Inc. InterMune. Ironwood Pharmaceuticals, Inc. Lexicon Pharmaceuticals. Inc., Neurocrine Biosciences Inc, NPS Pharmaceuticals, Ophthotech Corp. Pharmacyclics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc., Relypsa ... Infinity Pharmaceuticals Inc. InterMune, Ironwood Pharmaceuticals. Inc., Lexicon Pharmaceuticals. Inc.. Neurocrine Biosciences Inc, NPS Pharmaceuticals. Ophthotech Corp. Pharmacyclics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc.. Relypsa ... Pharmaceuticals Inc, InterMune, Ironwood Pharmaceuticals, Inc.. Lexicon Pharmaceuticals. Inc.. Neurocrine Biosciences Inc. NPS Pharmaceuticals, Ophthotech Corp. Pharmacyclics Inc.. Portola Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc., Relypsa. Inc., Synageva

https://www.justice.gov/epstein/files/DataSet%209/EFTA01199408.pdf

EFTA01377713Set 10

1p612w

Square, while keeping our risk and fraud losses low. Our 3 Net promoter score (NPS) is an index ranging from -100 to 100 that measures the willingness of customers ... typically based on customer surveys. We conduct surveys of our sellers to assess our NPS on a quarterly basis. 113 http:/Mww.wc.gov/Archiectlear/data/1512673AXX11193125B369092/d937622dsla.htmf 11/6/20B 7:37:12 AM! CONFIDENTIAL - PURSUANT

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01377713.pdf

EFTA01366647Set 10

2015-07-201p691w

capacity factor. t is arable to be paid at the prevailing merchant rate NPS 981 Our NPS Stir projects are compnsed of thee saes located in Pend Supentrun are Lorrain

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01366647.pdf

EFTA01711574Set 10

2005-08-0281p20,685w

W • =Mobile=. Get more from life T-Mobile USA Law Enforcement Relations 4 Sylvan, Parsippany

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01711574.pdf

EFTA01459707Set 10

2016-01-121p655w

overseas investment mandate for National Falling domestic bond yields are pushing more Pension Service (NPS); and 3) encouraging overseas mergers and acquisitions. In our view, the measures investors to diversify ... likely to gradually reduce. As of the start of 0 3.0% CNI 2016, NPS is now allowed to reduce its FX hedge ratio on overseas bond investment by half

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01459707.pdf

EFTA01222675Set 9

1990-11-043p1,439w

line 11f or 11g, complete lines 11h and 11i. h Enter the assigned NPS project number or the pass-through entity's employer identification number (see instructions) i Enter ... date that the NPS approved the Request for Certification of Completed Work (see instructions) j Rehabilitation credit from an electing large partnership (Schedule K-1 (Form

https://www.justice.gov/epstein/files/DataSet%209/EFTA01222675.pdf

EFTA01222672Set 9

1990-11-043p1,328w

properties identified on line 11f, complete lines 11g and 11h. g Enter the assigned NPS project number or the pass-through entity's employer identification number (see instructions) h Enter ... date that the NPS approved the Request for Certification of Completed Work (see instructions) i Rehabilitation credit from an electing large partnership (Schedule K-1 (Form

https://www.justice.gov/epstein/files/DataSet%209/EFTA01222672.pdf

EFTA02681717Set 11

3p576w

/search?q=jeffrey+epste=n&safe=off&client=firefox- a&hs=tco&rls=org.mozilla=en-US:official&tbs=ppl_ids:--106435982743019328629- ,ppl_nps:Clare+O%=7Connor,ppl_aut:1> - in 138 Google+ circles Feb 28, 2011- The pervert ... org.m=zilla:en-US:official&tbs=ppl_ids:--106610046192173033978- ,ppl_nps:Am=er+Sutherland,ppl_aut:1> Feb 25, 2011 - Billionaire pervert=Jeffrey Epstein is back in New York City

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02681717.pdf

EFTA00810510Set 9

2017-06-3035p10,753w

increase over Q4. Current FMV: $139.5M While Breather has an extremely high NPS score (north of 70), which drives Multiple (Gross & Net): I.57x 11.34x significant organic demand ... Vienna Insurance Group. "Formula for startup success: Find large highly fragmented industry with low NPS; Together they have the magic fintech combo of one person who can write beautiful vertically

https://www.justice.gov/epstein/files/DataSet%209/EFTA00810510.pdf

EFTA00266322Set 9

2009-09-1844p10,962w

Official Receipt Customer ABN: Customer ID: 62070240 32 CMR Date:09 Aug 2012 NPS Batch: 5 Non NPS Batch: Description Amount Trade Marks SI80.00 TOTAL $180.00 Reference: Trade Marks

https://www.justice.gov/epstein/files/DataSet%209/EFTA00266322.pdf

EFTA01459608Set 10

2016-01-121p655w

overseas investment mandate for National Falling domestic bond yields are pushing more Pension Service (NPS); and 3) encouraging overseas mergers and acquisitions. In our view, the measures investors to diversify ... likely to gradually reduce. As of the start of 0 3.0% CNI 2016, NPS is now allowed to reduce its FX hedge ratio on overseas bond investment by half

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01459608.pdf